Furthermore, metabolic parameters of tumor and peritumoral areas and their respective ratios to background were significantly higher in patients with PLC than in those without PLC4, and sensitivity and specificity of FDG PET for PLC were 86% and 100%, respectively9. This evidence concerns the gene HSPG2 and neoplasm.